Geron corp (GERN)
Balance Sheet / Yearly
Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Dec'10
ASSETS
Current assets:
Cash and cash equivalents

13,644

20,751

17,710

6,800

10,575

12,729

19,127

7,912

16,335

9,904

6,606

14,861

12,810

5,883

8,199

12,802

21,248

16,823

15,798

10,182

42,796

7,600

9,520

11,324

12,990

9,591

8,834

15,505

22,063

16,008

14,123

19,031

16,105

33,975

32,019

45,972

Restricted cash

270

270

270

270

269

269

269

268

268

268

268

268

268

268

267

267

267

266

266

266

266

265

795

795

795

795

795

794

794

794

794

793

793

793

793

792

Marketable securities

125,681

117,860

134,778

145,180

152,714

153,622

-

-

78,351

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Marketable securities

-

-

-

-

-

-

141,800

81,868

-

86,991

88,239

84,432

102,035

102,655

102,402

96,846

92,524

102,857

122,214

135,655

108,645

118,801

130,816

133,869

52,234

56,617

61,966

63,534

73,472

84,443

104,050

100,394

105,208

108,127

119,756

140,599

Interest and other receivables

802

795

838

976

1,168

778

773

569

436

514

457

597

475

-

586

624

1,206

1,238

1,505

1,190

963

787

1,256

1,439

564

555

480

921

752

842

932

866

1,398

1,569

1,630

1,799

Prepaid and other current assets

1,211

2,445

1,166

-

1,332

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Litigation settlement insurance recovery

-

-

-

-

-

-

-

-

-

-

6,000

6,000

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest and other receivables

-

-

-

-

-

-

-

-

-

-

-

-

-

5,404

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Prepaid assets

-

-

-

2,723

-

1,476

301

512

580

886

496

405

524

846

248

416

647

831

415

604

736

739

205

249

474

844

356

822

1,336

959

946

1,438

2,121

2,840

2,996

5,855

Total current assets

141,608

142,121

154,762

155,949

166,058

168,874

162,270

91,129

95,970

98,563

102,066

106,563

116,112

115,056

111,702

110,955

115,892

122,015

140,198

147,897

153,406

128,192

142,592

147,676

67,057

68,402

72,431

81,576

98,417

103,046

120,845

122,522

125,625

147,304

157,194

195,017

Noncurrent marketable securities

19,651

20,404

9,497

17,871

18,582

18,143

-

-

14,241

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Noncurrent marketable securities

-

-

-

-

-

-

20,250

13,184

-

15,560

22,076

22,126

13,954

21,005

25,523

31,976

32,661

31,821

18,734

17,739

18,932

15,801

6,496

7,464

-

-

-

-

-

5,726

3,283

16,712

32,133

37,921

39,592

33,911

Noncurrent portion of prepaid assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

108

854

Investments in licensees

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

2

504

Property and equipment, net

408

348

100

89

59

66

71

86

102

121

140

158

183

170

191

212

207

183

151

171

173

63

60

77

92

116

566

866

974

1,431

1,240

1,074

1,241

2,247

2,514

3,088

Operating leases, right-of-use assets

2,497

349

402

571

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deposits and other assets

1,353

-

-

-

585

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other assets

-

1,032

1,464

1,186

-

851

676

1,114

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deposits and other assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

191

191

191

195

195

414

410

410

825

825

879

1,048

932

920

210

Total assets

165,517

164,254

166,225

175,666

185,284

187,934

183,267

105,513

110,313

114,244

124,282

128,847

130,249

136,231

137,416

143,143

148,760

154,019

159,083

165,807

172,511

144,247

149,339

155,408

67,344

68,713

73,411

82,852

99,801

111,028

126,193

141,187

160,047

188,404

200,330

233,584

LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Accounts payable

1,181

2,031

1,210

913

982

190

458

502

503

261

205

308

225

271

235

396

160

574

957

1,180

1,033

2,365

1,223

1,520

1,397

1,547

1,176

1,669

3,429

3,014

3,429

2,666

2,980

4,006

3,471

3,462

Accrued compensation and benefits

4,830

3,443

2,756

1,661

2,642

1,833

1,531

1,100

3,385

2,651

2,056

1,489

2,843

2,205

2,311

1,619

3,026

2,248

1,731

2,135

4,213

2,685

2,186

1,556

3,946

2,886

2,046

1,664

5,216

3,907

3,421

1,774

3,029

2,855

2,305

6,186

Amount due to Janssen Biotech, Inc.

14,269

1,208

1,576

2,071

2,610

-

-

-

1,702

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Operating lease liabilities

354

349

402

571

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accrued collaboration charges

-

-

-

-

-

1,560

2,192

1,841

-

1,946

1,907

2,495

3,367

3,398

3,420

3,537

2,328

2,498

1,901

626

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other accrued liabilities

-

-

-

-

-

884

724

942

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Litigation settlement payable

-

-

-

-

-

-

-

-

-

-

6,250

6,250

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accrued restructuring charges

-

-

-

-

-

-

-

-

-

-

-

-

-

13

19

35

-

78

205

316

-

-

-

11

94

161

374

843

1,972

90

734

1,417

3,730

-

-

0

Accrued liabilities

7,528

4,831

3,237

1,037

1,317

-

-

-

926

1,112

856

1,054

1,434

1,432

1,126

1,071

1,120

727

933

1,375

1,537

2,018

1,057

1,286

1,783

1,985

1,358

2,591

3,480

4,171

4,378

4,379

3,641

3,005

3,066

2,644

Stock issuance obligation

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

27,500

Deferred revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

35,000

35,000

35,000

-

-

-

-

-

-

-

-

-

-

-

-

0

0

350

Fair value of derivatives

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

16

1

290

143

367

258

50

-

51

-

-

-

-

-

-

-

Fair value of derivatives

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

26

-

74

30

38

64

137

428

707

Fair value of derivatives

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

30

38

-

137

428

707

Total current liabilities

28,162

11,862

9,181

6,253

7,551

4,467

4,905

4,385

6,516

5,970

11,274

11,596

7,869

7,319

7,111

6,658

6,634

6,125

40,727

40,632

41,799

7,069

4,756

4,516

7,587

6,837

5,004

6,793

14,148

11,256

11,992

10,274

13,444

10,003

9,270

40,849

Noncurrent operating lease liabilities

2,200

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Long-term debt

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3,194

-

-

Commitments and contingencies

-

-

-

-

-

0

0

0

-

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

Stockholders' equity:
Preferred stock, $0.001 par value; 3,000,000 shares authorized; no shares issued and outstanding at December 31, 2019 and 2018

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

0

-

-

-

0

-

-

-

0

-

-

-

0

-

-

-

0

-

-

0

Common stock, $0.001 par value; 450,000,000 shares authorized; 199,814,581 and 186,392,682 shares issued and outstanding at December 31, 2019 and 2018, respectively

200

193

187

186

186

186

183

161

160

159

159

159

159

159

159

159

159

158

158

158

157

157

157

157

131

129

130

130

130

131

131

132

131

132

131

123

Additional paid-in capital

1,214,835

1,202,902

1,192,338

1,190,651

1,189,194

1,187,557

1,176,823

1,092,931

1,089,684

1,086,578

1,084,440

1,082,270

1,080,198

1,078,170

1,075,922

1,073,515

1,070,567

1,067,712

1,065,352

1,062,782

1,059,072

1,056,543

1,054,383

1,052,028

952,403

945,241

943,518

942,192

939,867

938,080

936,719

935,069

932,066

928,898

925,098

881,358

Accumulated deficit

-1,080,012

-1,050,942

-1,035,762

-1,021,523

-1,011,464

-1,004,164

-998,567

-991,633

-985,840

-978,411

-971,512

-965,107

-957,924

-949,442

-945,866

-937,229

-928,387

-919,919

-947,104

-937,748

-928,433

-919,486

-909,937

-901,203

-892,763

-883,482

-875,228

-866,281

-854,384

-838,521

-822,568

-804,242

-785,503

-753,649

-734,127

-688,650

Accumulated other comprehensive gain (loss)

132

239

281

99

-183

-112

-77

-331

-207

-52

-79

-71

-53

25

90

40

-213

-57

-50

-17

-84

-36

-20

-90

-14

-12

-13

18

40

82

-81

-46

-91

-174

-42

-96

Total stockholders' equity

135,155

152,392

157,044

169,413

177,733

183,467

178,362

101,128

103,797

108,274

113,008

117,251

122,380

128,912

130,305

136,485

142,126

147,894

118,356

125,175

130,712

137,178

144,583

150,892

59,757

61,876

68,407

76,059

85,653

99,772

114,201

130,913

146,603

175,207

191,060

192,735

Total liabilities and stockholders' equity

165,517

164,254

166,225

175,666

185,284

187,934

183,267

105,513

110,313

114,244

124,282

128,847

130,249

136,231

137,416

143,143

148,760

154,019

159,083

165,807

172,511

144,247

149,339

155,408

67,344

68,713

73,411

82,852

99,801

111,028

126,193

141,187

160,047

188,404

200,330

233,584